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Background. In Australia most chronic disease management is funded by Medicare Australia through General Practitioner Man-
agement Plans (GPMPs) and Team Care Arrangements (TCAs). Identiﬁed barriers may be reduced eﬀectively using a broadband-
based network known as the Chronic Disease Management Service (CDMS). Aims. To measure the uptake and adherence to
CDMS, test CDMS, and assess the adherence of health providers and patients to GPMPs and TCAs generated through CDMS.
Methods. A single cohort before and after study. Results. GPMPs and TCAs increased. There was no change to prescribed medicines
orpsychologicalqualityoflife.Attendanceatalliedhealthprofessionalsincreased,butdecreasedatpharmacies.Overallsatisfaction
with CDMS was high among GPs, allied health professionals, and patients. Conclusion. This study demonstrates proof of concept,
but replication or continuation of the study is desirable to enable the impact of CDMS on diabetes outcomes to be determined.
1.Introduction
The Chronic Disease Management Network (CDM-Net)
project developed, implemented, and evaluated a broad-
band-based network of health services known as the Chronic
Disease Management Service (CDMS) for managing chronic
disease, using type 2 diabetes mellitus (T2DM) as the test
disease.
A number of electronic systems are currently being used
to enhance diabetes care including diabetes registers, clinical
decision support systems, and web-based management pro-
grams. In order to ﬁnd studies that evaluated information
technology-based interventions that assist GPs to care for
patients with diabetes, it was necessary to search the interna-
tional literature, which could indicate that there is a pressing
need to use the technology available for use in general
practice in Australia to provide the best care for patients [1].
T2DM is a chronic progressive disease associated with
high morbidity and mortality rates and currently aﬀects an
estimated 1.7 million Australians [2, 3]. T2DM accounts for
85% to 90% of all diagnosed cases of diabetes with life-
style factors such as inactivity, obesity, and calorie-dense
diets contribute to the increasing prevalence of T2DM [2].
Key diabetes management targets include achieving and
maintaining HbA1c levels at less than 7%, normal lipids, pre-
venting diabetes complications, appropriate self-care and
optimal quality of life [4]. Management is generally under-
taken by general practitioners (GPs) supported by an inter-
disciplinary health care team.
In Australia, most chronic disease management under-
taken by GPs is underwritten by Medicare Australia [5],
and for eligible allied health services such as chiropractors,
diabetes educators, dietitians, podiatrists, and others, and
under certain conditions, can claim under Medicare Items
10950 to 10970 [6]. GPs receive ﬁnancial incentives to use
structured chronic disease care plans through Medicare
Enhanced Primary Care (EPC) Item numbers for General
Practitioner Management Plans (GPMPs Item 721) and are2 International Journal of Family Medicine
encouraged to collaborate with allied health providers and
other health care professionals when developing Team Care
Arrangements (TCAs Item 723) [4, 7].
While a steady increase in the number of GPMPs and
TCAs has been reported, less than 14% of patients with
chronic disease have a GPMP and/or a TCA [8]. In addition,
Medicare claims data suggest only one in ﬁve of these plans is
regularly followed up and reviewed at the recommended fre-
quency [9] even though research suggests that patients with
chronic disease may be hospitalised less frequently if they
receive optimal care [10]. Conversely, improved outcomes
for patients with diabetes have been reported when GPMPs
and TCAs are used [11, 12], partly because of the structur-
ed and systematic approach to care.
Barriers identiﬁed by GPs for not using GPMPs include
time constraints and diﬃculty communicating with other
health providers [13]. Some barriers such as communication
couldbereducedbyeﬀectivelyusinginformationtechnology
(IT), particularly since the introduction of IT into general
practice in Australia in 1999 [14]. Nonetheless, greater in-
tegration of IT into general practice and allied health care
providers is still needed [15, 16].
The CDM-Net project was a collaborative project devel-
oped and evaluated during 2007–2009 involving 12 Aus-
tralian and international organisations including an external
provider, Precedence Health Care. There were two parts to
the project: ﬁrst the development and formative evaluation
of the Chronic Disease Management System (CDMS) to fa-
cilitate GPs’ use of GPMPs and TCAs and collaboration be-
tweenGPs,andotherhealthprofessionals;thesecond,toeva-
luate the clinical utility and health professionals’ acceptance
of the system. The latter is described in this paper.
During the project there was no charge to the GPs for the
useoftheCDMS.Atthecompletionoftheproject,abusiness
arrangement was proposed by Precedence Health Care for
the participating GPS to consider and/or take up for future
use of CDMS.
CDMS is a secure broadband-based web-based inter-
active software service that complies with Commonwealth
and State requirements and the National eHealth Transition
Authority standards and guidelines. CDMS interfaces to
electronic health records, e-referral and messaging services,
and hospitals. The communications infrastructure required
byCDMSisprovidedbyexistingpublicbroadbandnetworks
and provides three innovative services:
(1) continuous, real-time chronic disease care surveil-
lance,
(2) a mechanism to track process (GPMPs, TCAs, medi-
cations, and investigations)
(3) an automated open broadband infrastructure [1].
The system delivers collaborative chronic disease man-
agement via the Internet utilising electronic applications in-
cluding:
(i) remote monitoring; patients upload information
such as blood glucose results to the Internet or the
health professionals’s computer,
(ii) email communication among GPs, other health pro-
fessionals, and patients,
(iii) Internet-delivered health education information,
(iv) interactive electronic medical records, available to
both health professionals and patients [1].
During the planning and development process for
GPMPs and TCAs, relevant patient information is encrypted
using a public key infrastructure certiﬁcate installed on GPs’
computers and sent electronically to the external provider
Precedence Health Care. Once registered as a CDMS user,
usersareprovidedwithapersonalisedsecurelog-inandpass-
word to enable access to the CDMS website [1].
When using CDMS, the process commences when a
GP assesses a patient and forwards a referral to Precedence
Health Care. All steps are completed electronically; CDMS
c r e a t e saG P M Pw h i c hi sr e t u r n e dt ot h eG Pf o ra p p r o v a l .
Once approved and returned to Precedence Health Care, the
option to create a TCA can be enabled by ticking a box. The
GPMP is then forwarded electronically to allied health pro-
fessionals who are generally known to the GP for agreement
to participate. For this work, eligible allied health profession-
als can claim payment using Medicare Items 10950 to 10970,
or are paid by the patients for services. The relevant docu-
mentationiselectronicallygenerated,signed,anddistributed
to the care team and patient. CDMS tracks the GPMP and
TCA and patient outcomes such as medications, biomedical
measurements, and appointments. When reviews are due,
CDMS automatically generates and electronically forwards
an alert to the GP, summarises the relevant information, and
automatically creates a draft GPMP review for the GP to
approve [1].
2.Methodology
2.1. Aim
(1) To measure the uptake and adherence to CDMS
GPMPs and TCAs, clinical health, quality of life indi-
cators, and patients’ biomedical parameters.
(2) To test the broadband-based network (CDMS) in
general practice in the Barwon South West Region
Victoria.
(3) To assess the adherence of both health providers
and patients to GPMPs and TCAs generated through
CDMS.
2.2. Method. A single cohort before and after study, initially
with a nine-month intervention period, with two participant
groups: GPs and patients with T2DM. The study period was
extended with an additional 6 months, resulting in a fourth
datacollectionaftertheinitialnine-monthinterventionperi-
od.
2.2.1. Recruitment. GP recruitment commenced in July 2008
and ceased at the end of January 2009.
Patients were recruited by their GPs from August 2008
and ceased in February 2009.International Journal of Family Medicine 3
Table 1: The number of patients in the study at each time point, the number of patients included in the ﬁnal analysis, and the percentage of
participants retained from Time 1 to Time 3.
Time 1 Time 2 Time 3 % retained % retained
Time 1 to Time 2 Time 1 to Time 3
Number of patients who completed the
questionnaire 113 107 94 95% 83%
Number of patients included in the ﬁnal
analysis 99 93 80 94% 81%
2.2.2. GPs—Inclusion Criteria
(1) Agree to participate in and support the study and
attend three workshops.
(2) Have either Medical Director 3 or Best Practice medi-
cal software.
2.2.3. Patient Inclusion Criteria
(1) Diagnosis of type 2 diabetes.
(2) Age range 18–75 years.
(3) Accessandabilitytouseamobilephone,theInternet,
or a landline telephone.
(4) Living independently.
(5) Provide informed consent to share their health infor-
mation electronically with Precedence Health Care
and the interdisciplinary care team.
2.2.4. Patient Exclusion Criteria
(1) Pregnant women.
(2) Diagnosis of HIV/AIDS.
2.2.5. Data Collection. The majority of data were collected at
three time points during eleven months; Time 1: at the com-
mencement of the intervention period, Time 2: approxi-
mately half way between Time 1 and Time 3, and Time 3:
at the completion of the intervention period (T3). A fourth
datasetwascollectedaftertheinterventionperiod,duringthe
6-month extension to the project, and it included metabolic
parameters.
GP data were collected using ﬁeld notes, information
compiled at three interactive information workshops, and
individual interviews.
Patient data were collected using (a) questionnaires, in-
cluding the Kessler Psychological Distress Scale-10, and the
Control Preference Scale at Time1 and Time 3; (b) CDMS-
generated GPMPs and TCAs at Times 1, 2, 3 and 4; (c)
Barwon Health.
Outcome indicators included the following:
(i) the number of GPMPs created
(ii) the number of GPMP reviews conducted (because
of the limited study period, only the ﬁrst 6-monthly
reviews could be conducted)
(iii) the number of services carried out as recommended
by best-practice guidelines, and the number of inves-
tigations completed for the patient cohort:
(1) biomedical (e.g., HbA1c, lipids),
(2) allied health services,
(3) home medicines reviews,
(4) use of services at Barwon Health.
2.2.6. Data Analysis. Quantitative data were analysed using
statisticalpackageSPSSv.17.Thelevelofobservedeﬀectswas
determinedusingat-test.ThefollowupratioforGPMPsand
TCAswascalculatedfor“beforeandafter”,butwaslimitedto
the “ﬁrst reviews”.
Qualitative data from the workshops and interviews
were analysed using thematic analysis [17]. Data were
analysed according to the Framework Method [18]a n d
veriﬁed independently by two investigators. When there was
ad i ﬀerence of opinion, the investigators discussed the issues
to reach agreement [18].
2.2.7. Ethics. Ethics approval was obtained from Barwon
Health Research Ethics Advisory Committee and Monash
University Standing Committee on Ethics in Research In-
volving Humans, and noted by the Deakin University Hu-
man Research Ethics Committee.
3. Results
Twelve GPs from seven general practices and 113 patients
agreed to participate. No GPs withdrew during the inter-
vention period; 14 patients did not provide all the required
data as the study progressed, hence the ﬁnal patient data
set comprised 99 patients at Time 1, 93 at Time 2, 80 at
Time 3 and 80 at Time 4 (Table 1). At Time 1, the 99 cohort
comprised 61 males and 38 females with an age range of
31 to 83 years; 83% were Australian born and 64% lived at
home with their spouses. For the 99, the duration of their
diabetes ranged from a new diagnosis to 34 years, and 78%
were registered with the National Diabetes Services Scheme.
3.1. Uptake of and Adherence to CDMS GPMPs and TCAs,
Clinical Health, Quality of Life Indicators, and Patients’
Biomedical Parameters, Medicines Proﬁle, and Use of Barwon
Health Services. According to practice management data for
the two years prior and the one year after the introduction of
CDMS, the number of GPMPs (Item 721) and TCAs (Item
723) claimed by participating GPs during the intervention
period increased (Table 2). Because of the limited study
period, only the ﬁrst 6-monthly GPMP (Item 725) and
TCA (Item 727) were tracked. Nonetheless, this suggests
that the use of CDMS has an inﬂuence on increasing the4 International Journal of Family Medicine
Table 2: The number of MBS CDM Items for all chronic diseases claimed by GPs in the 2-year period prior to, and 12 months after
implementing CDMS (data not provided by all participating GPs).
GP
Prior to CDMS–2007/2008 (from practice data) After CDMS–2008/2009 (from practice data)
721 723 725 727 721 723 725 727
1 70709594
2 ————————
3 2 582 502 132 20
4 1 71 71 91 72 82 83 63 5
5 1 42 7 31 631 95
6 634 — 1 9 1 5 7 —
7 30000000
8 9571 — 4 1 7 1
9 2 43 52 25 42 62 92 62 0
1 0 ————————
1 1 31 07 81 09 7 8
12 63 45 3 7 45 23 0 14
Table 3: Patient Self-reported blood glucose and blood pressure monitoring practices during the intervention period (n = 99).
Item (n patients who responded to each item) Yes (%) No (%) Unsure (%)
Measure blood glucose with a glucose meter (n = 99) 74 (75) 24 (24) 1 (1)
Measure blood pressure (n = 98) 19 (19) 79 (80) —
Record BG and BP test results in a record book (n = 91) 39 (39) 52 (53) —
Download BG test results to a personal computer (n = 96) 3 (3) 92 (93) 1 (1)
number of followups (Items 725, 727), and also suggests that
considerable improvement can still be achieved by most GPs
who participated in this study.
3.1.1. Clinical Health. Duration of diabetes diagnosis ranged
from a new diagnosis to 34 years, with 78% registered with
the National Diabetes Services Scheme. The majority of
patients reported self-monitoring their blood glucose. Self-
monitoringwasassociatedwithalongerdurationofdiabetes,
lowermeanHbA1c,olderage,lowermeancholesterol,having
a GPMP prior to the introduction of the broadband-based
service, CDMS (Table 3).
The trend suggests that females were more likely than
males to monitor their blood glucose and write their results
in a record book.
3.1.2. Quality of Life Indicators. The Kessler Psychological
Distress Scale-10 was measured at Times 1, 2, and 3. Overall,
low levels of distress were reported. There was very little
change in total scale scores for patients over time and gender,
but those patients who reported having a disability (n = 20)
had slightly higher distress scores at each time point than
those who did not report a disability (n = 71).
The Control Preference Scale was measured at Times 1
and 3, to assess patient’s preferred level of involvement in
medical decision-making. Forty-one (41%) patients at Time
1, and 31 (31%) patients at Time 3 indicated they preferred
to share responsibility for decision-making with their GP.
However, 17 (17%) patients at Time 1 and 21 at Time 3
(26%) indicated they preferred the doctor to make the ﬁnal
decision. There was no signiﬁcant change in patients’ self-
reported medical decision-making preference style between
Times 1 and 3.
3.1.3. Patients’ Biomedical Markers. Eight metabolic param-
eters were recorded during the intervention period. Not all
patients had measurements recorded at more than one time
point,andthereforedataareforthesubsetsofpatients.Mean
HbA1c decreased from 7.41% (Time 1) to 7.05% (Time 4)
(n = 23); low-density lipoprotein decreased from 2.24 (Time
1) to 1.96 (Time 4) (n = 17); triglycerides from 2.21 (Time
1) to 1.89 (Time 4) (n = 19) and total cholesterol from 4.31
( T i m e1 )t o4 . 0 4( T i m e4 )( n = 19) (Table 4).
At Time 1, blood pressure was recorded for every patient
in the study, HbA1c, HDL, LDL, triglycerides, and total cho-
lesterol were recorded for more than half the sample and
microalbumin was recorded for just under a third of the
sample.
3.1.4. Medicines Proﬁle. Prescribed medicines were recorded
for 96 of the 99 participants during the intervention period.
Patients were prescribed between zero and 23 medicines at
Time 1. Patients aged >66 years were prescribed a greater
number of medicines (range 0–23 medicines) compared to
patients aged <65 years (range 0–18 medicines). The rela-
tionship between the number of prescribed medicines
and gender or income was not signiﬁcant. Duration of
diabetes was longer for patients prescribed one or more
diabetes medicines (oral hypoglycaemic agents (OHAs),
insulin, lipid lowering agent, and antihypertensive agent)International Journal of Family Medicine 5
Table 4: The number of patients at each time point who had metabolic parameters recorded (n = 99).
Metabolic parameter Time 1 n (%) Time 2 n (%) Time 3 n (%) Time 4 n (%)
HbA1c 50 (51%) 6 (6%) 15 (15%) 23 (23%)
Microalbumin 31 (31%) 2 (2%) 3 (3%) 13 (13%)
Systolic blood pressure 99 (100%) 13 (13%) 15 (15%) 35 (35%)
Diastolic blood pressure 99 (100%) 13 (13%) 15 (15%) 35 (35%)
High-density lipoprotein (HDL) 53 (54%) 6 (6%) 10 (10%) 15 (15%)
Low-density lipoprotein (LDL) 52 (53%) 5 (5%) 10 (10%) 15 (15%)
Triglycerides 53 (54%) 6 (6%) 9 (9%) 16 (16%)
Total cholesterol 55 (56%) 6 (6%) 10 (10%) 16 (16%)
Table 5: The characteristics of patients who used at least one Barwon Health service (n = 99).
Characteristic Patients who used at least one BH service
(n = 57/99 = 57%)
Patients who did not use any BH services
(n = 42/99 = 42%)
Male 61.4 61.9
Female 38.6 38.1
Percent reporting they self-monitor
blood glucose 73.7 76.2
Mean age (years) 67.81 61.74
Mean duration of diabetes (years) 8.23 7.46
Mean weight (kg) 91.51 91.45
Mean body mass index (kg/m2) 31.96 32.53
Mean HbA1c (%) 7.08 8.65
than patients not prescribed one of these medicines. There
were no changes to recorded prescribed medications or dose
regimens at Times 2, 3, or 4. Seventy-one patients were
prescribedoralhypoglycaemicagents.Amongthe66patients
with HbA1c recorded at Time 4, those prescribed an oral
hypoglycaemic agent (n = 46) had signiﬁcantly higher
HbA1c than patients not prescribed an oral hypoglycaemic
agent (n = 20).
3.1.5. Barwon Health Service Use. During the CDMS inter-
vention, six types of services were used by this patient cohort
available through Barwon Health:
(i) hospital admissions,
(ii) allied or community health visits,
(iii) emergency department,
(iv) medical imaging,
(v) outpatients,
(vi) pathology.
Of the 99 patients, 42 did not use any of the above
Barwon Health services, 26 used one service, 13 used two
services, two used three services, six used four services, eight
used ﬁve services and two patients used all six services.
Patients aged ≥66 years were more likely to use one or more
Barwon Health services than those aged ≤65 years. There
were no signiﬁcant diﬀerences in services used between the
genders. There was a trend indicating patients who used at
least one Barwon Health service had a longer duration of
diabetes and lower HbA1c at Time 1 than those who did not
use a Barwon Health service (Table 5).
Patients made between zero and 230 attendances to
one or more BH service. Two patients had extremely high
numbers of attendances (177 and 230). Excluding the two
extremecases,BarwonHealthattendancesperpatientranged
between zero to 125.
3.2.ToTesttheBroadband-BasedNetwork(CDMS)inGeneral
PracticeintheBarwonSouthWestRegionVictoria. Allpartic-
ipants were asked about the advantages and disadvantages,
and their satisfaction of the CDM-Net care planning system.
Thequalitativeresultsindicatedthat,whiletherewaspositive
critical feedback of CDMS in the early development stages,
overall feedback about CDMS use and the impact of the
system to diabetes management was positive. Most health
professionals felt that sharing patients’ health information
electronically was helpful and made a diﬀerence to the care
they provided, thus interdisciplinary communication was
enhanced. Regarding their satisfaction with the implemen-
tation and use of CDMS, health professionals, including
GPs, identiﬁed advantages and disadvantages. Advantages
included improved communication between health profes-
sionals, individual providers able to electronically update
the GPMP and TCA, saves paperwork, faxing, and time;
disadvantages included that the current version of CDMS is
not user friendly, it is tedious to update documents, and it
is something else to take up a good bit of time. These re-
sponses reﬂected individuals’ involvement in the study and
are reported more extensively elsewhere.6 International Journal of Family Medicine
Table 6: Patients’ attendances at ﬁve categories of health professionals within the last three months, including the range and duration of
attendances reported at Time 1 (n = 99), Time 2 (n = 93), and Time 3 (n = 80).
Patients who attended (%) Range of attendances per patient
Health Professional Time 1 Time 2 Time 3 Time 1 Time 2 Time 3
Pharmacist 90 (91) 74 (80) 76 (95) 0–40 0–12 0–24
Podiatrist 39 (39) 51 (55) 42 (53) 0–6 0–6 0–3
Optometrist 34 (34) 28 (30) 30 (38) 0–5 0–10 0–5
Diabetes educator 18 (18) 31 (33) 17 (21) 0–5 0–12 0–2
Dietitian 9 (9) 26 (28) 23 (29) 0–3 0–3 0–6
3.3. Assess the Adherenceof Both Health Providers and Patients
to GPMPs and TCAs Generated through CDMS. Results sug-
gest that CDMS had a strong inﬂuence on increasing the
follow-up ratios for GPMPs and TCAs, with ﬁndings sug-
gesting considerable improvement can still be achieved by
most GPs who participated in this study Table 6.
4. Discussion
GPs using CDMS endeavoured to overcome some of the
major barriers to the uptake and use of GPMPs and TCAs
including diﬃculty ﬁnding time to develop and review
GPMPs and TCAs, the challenges of interdisciplinary com-
munication, the lack of eﬀective followup and review, and
support for patient self-management. In the ﬁrst instance,
GPs reported challenges with CDMs to the research team,
who in turn, reported this information to Precedence Health
Care. These challenges were usually addressed in the ongo-
ing developmental work that continued throughout the in-
tervention period. CDMS satisﬁed key technical issues by en-
crypting patient information using a public key infrastruc-
ture certiﬁcate installed on GPs’ computers.
While this project only considered the outcomes using
GPMPs and TCAs in one chronic disease, T2DM, in one
region of Victoria, the results suggest an increase in the
number of GPMPs and TCAs developed, increased com-
munication among the health providers, followup and re-
view of GPMPs and TCAs, and the use of guideline-based
services associated with T2DM management. Prescribed
medicines (type, dose, or dose interval) did not change
during the study, which is interesting given the trendtowards
improved metabolic status during the study [4, 7]. One
explanation could be that the level of change in biomedical
parameters did not provide suﬃc i e n te v i d e n c ef o rG P st o
consider changing medication. Another reason could be that
the change in biomedical parameters could be attributed to
lifestyle change, or to participating in this study [19]. Phar-
macy attendances decreased during the intervention peri-
od but the reason for this is not clear; patients may have
changed the frequency and/or location of when/where they
collected prescribed medicines.
Allied health service use increased during the study.
While the number of reported diabetes educator attendances
increased at T2 during the intervention period, less than
50% of the sample reported attending a diabetes educator.
Reasonsforthismaybethatsomepatientsdidnotrequirethe
servicesofadiabeteseducatorduringthestudy;alternatively,
the relatively low rate of reported diabetes educator atten-
dances could reﬂect a lack of diabetes educator resources in
the Barwon South West Region. During the intervention pe-
riod, 19 diabetes educators worked in the Barwon South
West Region to provide services for the 10,074 individuals
diagnosed with diabetes [20]. The average waiting time for
an appointment with a diabetes educator was two weeks
in the hospital diabetes service but waiting times to access
diabetes educators in the community were not available. The
allocation of ﬁve visits per year to allied health professionals
mightnotbeenough[6],especiallyforhighriskpatientsand
those with complex care needs, as well as for women during
pregnancy.
The results suggest that information technologies, par-
ticularly when focused on improved processes of care, better
collaboration,andincreasedpracticeproductivity,maymake
asigniﬁcantdiﬀerencetoGPs’useofGPMPsandTCAsinthe
treatment of patients diagnosed with a chronic illness.
5. Strengths and Limitationsof the Study
5.1. Strengths. The study was undertaken in a “real-life” clin-
ical setting in which GPs, practice nurses, and allied health
professionals were engaged in chronic disease management
prior to implementing CDMS. CDMS-generated GPMPs
and TCAs contained comprehensive diabetes-related clinical
information including metabolic parameters, prescribed
medicines, and medical complications.
5.2. Limitations. Without a comparison group, it is not clear
whether changes in allied health service use were due to
GPMP and/or TCA use, to CDMS or to other unrelated
factors.LowrecruitmenttotheCDM-Net(research)compo-
nent may have been due to GPs not having the appropriate
software, a reluctance to change from a paper base system
to a broad-based service, or that practice staﬀ had expressed
concern about their ongoing employment if the CDMS
system was utilised in the practice.
More research that compares CDMS GPMPs and TCAs
to GPMPs and TCAs developed not using CDMs is necessary
to evaluate the impact of CDMS on allied health service use.
Replication or continuation of the study is desirable to
enable the impact of CDMS on diabetes outcomes to be
determined. In particular, the study should include GPs and
patients from other divisions of general practice, and female
and solo GPs.International Journal of Family Medicine 7
6. Conclusions
CDMS was associated with small, nonsigniﬁcant reduction
in lipid levels (low-density lipoprotein, triglycerides, and
total cholesterol) and mean HbA1c.
There was no change to recorded prescribed medicines
or quality of life, but the use of allied health services
appeared to increase during the intervention period. Despite
an initial lack of satisfaction with certain aspects of CDMS’s
functionality identiﬁed by allied health professionals, overall
satisfaction with CDMS was high among GPs, allied health
professionals, and patients.
The utility of IT-enabled interventions may lie in their
ability to facilitate communication among health care pro-
viders, and between health care providers and patients. Fur-
ther research is needed to delineate the contribution of
CDMSandIT-enabledinterventionstochronicdiseaseman-
agement within the Australian context of GPMPs and TCAs.
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